HYDROSEPTINE- zinc oxide, menthol ointment 
AKRON PHARMA INC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

MEDPURA
Hydroseptine Ointment
Protects, Soothes, Helps Promote Healing

Active Ingredients 

Menthol 0.44%

Zinc Oxide 20.6%

Purpose

Active Ingredients                                        Purpose
Menthol 0.44%...........................External analgesic/anti-itch
Zinc Oxide 20.6%......Skin protectant/anorectal astringent 

Uses

Warnings

For external use only

When using this product

  • not for deep or punctured wounds
  • avoid contact with eyes

Stop use and ask doctor if

Keep out of reach of children.

Directions

Cleanse skin gently with mid skin cleanser. Pat dry or allow to air dry. apply a thin layer of Hydroseptine Ointment to reddened or irritated skin 2-4 times daily, or after each incontinent episode or diaper change to promote comfort and long lasting protection.

Inactive Ingredients:

Other information store at room temperature 15-30 C (59-86 F)

Inactive ingredients calamine, chlorothymol, glycerin, lanoline,phenol, sodium bicarbonate, and thymol in a suitable ointment base

Questions or Comments? Call toll-free 1-877-255-6999

Manufactured for:

Akron Pharma, Inc.

Fairfield, NJ 07004

www.akronpharma.com

This product is not manufactured or distributed by Calmoseptine Inc., owner of the registered trademark Calmoseptine.

100mg

HYDROSEPTINE 
zinc oxide, menthol ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71399-6743
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL0.44 g  in 100 g
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE20.6 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
FERRIC OXIDE RED (UNII: 1K09F3G675)  
CHLOROTHYMOL (UNII: LJ25TI0CVT)  
GLYCERIN (UNII: PDC6A3C0OX)  
LANOLIN (UNII: 7EV65EAW6H)  
PHENOL (UNII: 339NCG44TV)  
SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
THYMOL (UNII: 3J50XA376E)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71399-6743-1100 g in 1 JAR; Type 0: Not a Combination Product11/05/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34611/05/2021
Labeler - AKRON PHARMA INC (067878881)

Revised: 3/2023
Document Id: feee8437-d7d9-457d-9462-9620e8b3a4f6
Set id: 5359d92e-641e-4076-9d91-18daee58a30e
Version: 2
Effective Time: 20230310
 
AKRON PHARMA INC